Physician profile
Khin M Soe
NPI 1548247596
$7,074.34
in general payments reported to CMS, 2019-2025
15 companies · $889 in 2025
The $889 reported for 2025 was more than what 79% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,301 · 2020: $614 · 2021: $564 · 2022: $1,103 · 2023: $1,009 · 2024: $594 · 2025: $889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,491.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $2,534.32 | 2019-2024 | Abilify Maintena, Rexulti, Abilify Asimtufii |
| Teva Pharmaceuticals USA, INC. | $1,010.73 | 2019-2025 | Austedo Xr, Uzedy, Austedo |
| Abbvie INC. | $761.36 | 2021-2025 | Vraylar |
| Neurocrine Biosciences, INC. | $567.55 | 2019-2025 | |
| Axsome Therapeutics, INC. | $489.33 | 2023-2025 | Auvelity |
| Janssen Pharmaceuticals, INC | $385.00 | 2019-2023 | Invega Sustenna, Invega Trinza |
| Alkermes, INC. | $343.54 | 2019-2024 | Lybalvi |
| Allergan, INC. | $286.25 | 2019-2020 | |
| Shockwave Medical, INC | $156.66 | 2025 | |
| Avanir Pharmaceuticals, INC. | $125.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.92 | 2019 | |
| Sunovion Pharmaceuticals INC. | $118.48 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $115.31 | 2023 | |
| Gilead Sciences, INC. | $38.72 | 2019 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $17.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khin Soe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.